Nephrology Department, Strasbourg University Hospital, France.
Clin J Am Soc Nephrol. 2012 Mar;7(3):472-8. doi: 10.2215/CJN.00940111. Epub 2012 Jan 12.
Gitelman syndrome (GS) is a salt-wasting tubulopathy that results from the inactivation of the human thiazide-sensitive sodium chloride cotransporter located in the distal convoluted tubule. Tubular adaptation to renal sodium loss has been described and localized in the distal tubule in experimental models of GS but not in humans with GS.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The tubular adaptation to renal sodium loss is described. Osmole-free water clearance and endogenous lithium clearance with furosemide infusion are used to compare 7 patients with genetically confirmed GS and 13 control participants.
Neither endogenous lithium clearance nor osmole-free water clearance disclosed enhanced proximal fluid reabsorption in patients with GS. These patients displayed significantly lower osmole-free water clearance factored by inulin clearance (7.1 ± 1.9 versus 10.1 ± 2.2; P<0.01) and significantly lower fractional sodium reabsorption in the diluting nephron (73.2% ± 7.1% versus 86.1% ± 4.7%; P<0.005), consistent with the inactivation of the thiazide-sensitive sodium chloride cotransporter. The furosemide-induced reduction rate of fractional sodium reabsorption in the diluting segment was higher in patients with GS (75.6% ± 6.1% versus 69.9% ± 3.2%; P<0.039), suggesting that sodium reabsorption would be enhanced in the cortical part of the thick ascending limb of the loop of Henle in patients with GS.
These findings suggest that tubular adaptation to renal sodium loss in GS would be devoted to the cortical part of the thick ascending limb of the loop of Henle in humans.
吉特曼综合征(GS)是一种盐耗性管状病变,由位于远曲小管的人类噻嗪敏感钠氯共转运体失活引起。在 GS 的实验模型中,已经描述并定位了肾小管对肾钠丢失的适应性,但在 GS 患者中尚未发现。
设计、设置、参与者和测量:描述了肾小管对肾钠丢失的适应性。使用呋塞米输注时的无渗透溶质水清除率和内源性锂清除率来比较 7 名经基因证实的 GS 患者和 13 名对照参与者。
GS 患者的内源性锂清除率或无渗透溶质水清除率均未显示增强的近端液体重吸收。这些患者的无渗透溶质水清除率与菊粉清除率的比值明显较低(7.1 ± 1.9 对 10.1 ± 2.2;P<0.01),稀释性肾单位的钠重吸收率也明显较低(73.2% ± 7.1%对 86.1% ± 4.7%;P<0.005),与噻嗪敏感钠氯共转运体失活一致。GS 患者呋塞米诱导的稀释段钠重吸收分数降低率较高(75.6% ± 6.1%对 69.9% ± 3.2%;P<0.039),表明 GS 患者的厚升支袢粗段皮质部分的钠重吸收会增强。
这些发现表明,GS 中肾小管对肾钠丢失的适应性将集中在人类厚升支袢粗段的皮质部分。